Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marjana Serdarevic-Pehar"'
Autor:
Nazzareno Galiè, Gérald Simonneau, Vallerie V. McLaughlin, Thomas R. Fleming, Hossein Ardeschir Ghofrani, Michael Oakes, Marjana Serdarevic-Pehar, Gary Layton, David B. Badesch, Lewis J. Rubin, Robyn J. Barst
Publikováno v:
Chest. 140:1274-1283
Background The long-term safety and tolerability of sildenafil treatment of pulmonary arterial hypertension (PAH) were assessed. Methods Two hundred fifty-nine of 277 randomized and treated patients completed a 12-week, double-blind, placebo-controll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1faf029b9acf0381409e8dd76ccc2e82
https://doi.org/10.1378/chest.10-0969
https://doi.org/10.1378/chest.10-0969
Publikováno v:
International Journal of Clinical Practice. 61:1614-1625
Summary Objective: Inhaled human insulin (Exubera®; EXU) has shown encouraging tolerability in short-term trials. We evaluated the safety profile of EXU after long-term exposure. Design: In two, open-label, 2-year studies patients poorly controlled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ee7930c9cf3b1d80ca8dcb241537f61
https://doi.org/10.1111/j.1742-1241.2007.01522.x
https://doi.org/10.1111/j.1742-1241.2007.01522.x
Autor:
Olivier Sitbon, Gary Layton, Lewis J. Rubin, Marjana Serdarevic-Pehar, Mordechai R. Kramer, Nazzareno Galiè, Thomas R. Fleming, Robyn J. Barst, Peter J. Engel, David B. Badesch, Adaani E. Frost, Gérald Simonneau
BACKGROUND: In pulmonary arterial hypertension (PAH), adding oral sildenafil to intravenous epoprostenol improved 6-minute walk distance (6MWD) and hemodynamics and delayed time to clinical worsening in a 16-week randomized, placebo-controlled trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e3b043c5717e9c4f8066febd14f0908
http://hdl.handle.net/11585/534433
http://hdl.handle.net/11585/534433
Autor:
David L. Wessel, Marjana Serdarevic-Pehar, Robyn J. Barst, András Szatmári, Tomás Pulido, Gary Layton, D. Dunbar Ivy, Guillermo Gaitan, B.K.S. Sastry, Alberto E. Garcia, Andrzej Rudziński
Publikováno v:
Circulation. 125(2)
Background— Safe, effective therapy is needed for pediatric pulmonary arterial hypertension. Methods and Results— Children (n=235; weight ≥8 kg) were randomized to low-, medium-, or high-dose sildenafil or placebo orally 3 times daily for 16 we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::328c5c70b086da1e76bfcb3060b466d1
https://pubmed.ncbi.nlm.nih.gov/22128226
https://pubmed.ncbi.nlm.nih.gov/22128226
Publikováno v:
Diabetes care. 29(6)
To compare the efficacy and safety profile of adding inhaled human insulin (INH; Exubera) or metformin to sulfonylurea monotherapy in patients with poorly controlled type 2 diabetes.We performed an open-label, parallel, 24-week, multicenter trial. At
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b247cbf4f8a2c55e696e1c1326fe88fa
https://pubmed.ncbi.nlm.nih.gov/17213170
https://pubmed.ncbi.nlm.nih.gov/17213170